Drug Type Biological products |
Synonyms R-5780 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Rise Therapeutics LLCStartup |
Active Organization Rise Therapeutics LLCStartup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenoma | Phase 1 | - | Rise Therapeutics LLCStartup | 01 Sep 2024 |
Basal Cell Carcinoma | Phase 1 | - | Rise Therapeutics LLCStartup | 01 Sep 2024 |
Melanoma | Phase 1 | - | Rise Therapeutics LLCStartup | 01 Sep 2024 |
Squamous Cell Carcinoma | Phase 1 | - | Rise Therapeutics LLCStartup | 01 Sep 2024 |
Neoplasms | Discovery | US | Rise Therapeutics LLCStartup | - |